DV
Dividend Vision

AGNPF — Algernon Pharmaceuticals Inc

Algernon Pharmaceuticals Inc (AGNPF)

Its deepest 1-year drawdown was 64.1%.

AGNPF is a single-stock equity fund focused on Algernon Pharmaceuticals Inc, a healthcare company. The fund lacks a stated dividend distribution rate and does not currently offer regular distributions to shareholders. With limited publicly available information on expense ratio and assets under management, this fund appeals primarily to investors seeking direct exposure to Algernon Pharmaceuticals' business operations rather than those seeking income through dividends or distributions.

AGNPF key facts

Asset type
Stock
Asset class
Equity
Inception date
03/11/2016
Last close
$0.31
Market cap
$1,751,716
Average volume
2120.0
Payment date
10/17/2018
Beta
0.906
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.37